Endo Tools Therapeutics Secures $23 million in Series C Financing to Advance The endomina® technology and Commercialization of New endomina EZFuse System.
Endo Tools Therapeutics announced the closing of its Series C financing round, raising €20 million (approximately $23 million). This funding will be used to advance the commercialization of the endomina® platform in the U.S., Europe, and Middle East. The round was led by Capricorn Partners and supported by MGFO and existing investors. The new capital will help collect the necessary clinical evidence for a U.S
Company Information
Company
Endo Tools Therapeutics
Location
Belgium
About
Endo Tools Therapeutics (ETT) develops and markets advanced endoscopic medical devices. The company focuses on creating innovative solutions for various medical conditions, particularly those related to obesity. Their flagship product, the endomina® platform, enables minimally invasive endoscopic procedures for stomach volume reduction.
Fundz sees it the moment Endo Tools Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BelgiumManufacturingBiotechnologyHealth CareMedicalMedical Device